Oseltamivir Phosphate
Product Images NDC 53002-1655

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 53002-1655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (00c5b56c Ed16 48d6 9b77 Cd0277f99100 01)

Chemical structure of oseltamivir phosphate showing its molecular arrangement with ethyl ester, amine, and phosphate groups attached to a cyclohexene ring.*

FDA Label Image

Label Image (Lbl530021655)

The label for Oseltamivir Phosphate Oral Suspension, 6 mg/mL, by RPK Pharmaceuticals, Inc. It is a 60 mL bottle with instructions to take the medication twice a day for 5 days. The label includes usage directions, drug identification, and spaces for patient and prescriber information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.